1. Home
  2. ARTL vs OCTO Comparison

ARTL vs OCTO Comparison

Compare ARTL & OCTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARTL
  • OCTO
  • Stock Information
  • Founded
  • ARTL 2011
  • OCTO 1966
  • Country
  • ARTL United States
  • OCTO United States
  • Employees
  • ARTL N/A
  • OCTO N/A
  • Industry
  • ARTL Biotechnology: Pharmaceutical Preparations
  • OCTO
  • Sector
  • ARTL Health Care
  • OCTO
  • Exchange
  • ARTL Nasdaq
  • OCTO Nasdaq
  • Market Cap
  • ARTL 3.7M
  • OCTO 4.4M
  • IPO Year
  • ARTL N/A
  • OCTO N/A
  • Fundamental
  • Price
  • ARTL $1.21
  • OCTO $1.74
  • Analyst Decision
  • ARTL Strong Buy
  • OCTO
  • Analyst Count
  • ARTL 2
  • OCTO 0
  • Target Price
  • ARTL $5.50
  • OCTO N/A
  • AVG Volume (30 Days)
  • ARTL 28.9K
  • OCTO 1.6M
  • Earning Date
  • ARTL 11-12-2024
  • OCTO 11-14-2024
  • Dividend Yield
  • ARTL N/A
  • OCTO N/A
  • EPS Growth
  • ARTL N/A
  • OCTO N/A
  • EPS
  • ARTL N/A
  • OCTO N/A
  • Revenue
  • ARTL N/A
  • OCTO $39,835,256.00
  • Revenue This Year
  • ARTL N/A
  • OCTO N/A
  • Revenue Next Year
  • ARTL N/A
  • OCTO N/A
  • P/E Ratio
  • ARTL N/A
  • OCTO N/A
  • Revenue Growth
  • ARTL N/A
  • OCTO N/A
  • 52 Week Low
  • ARTL $0.91
  • OCTO $1.26
  • 52 Week High
  • ARTL $1.75
  • OCTO $4.86
  • Technical
  • Relative Strength Index (RSI)
  • ARTL 64.07
  • OCTO 49.02
  • Support Level
  • ARTL $1.09
  • OCTO $1.56
  • Resistance Level
  • ARTL $1.19
  • OCTO $2.22
  • Average True Range (ATR)
  • ARTL 0.06
  • OCTO 0.27
  • MACD
  • ARTL 0.01
  • OCTO -0.02
  • Stochastic Oscillator
  • ARTL 100.00
  • OCTO 20.20

About ARTL Artelo Biosciences Inc.

Artelo Biosciences Inc is a United States-based development-stage biopharmaceutical company. It is engaged in development of therapeutics that target lipid signaling pathways, including the endocannabinoid system, a family of receptors and neurotransmitters that form a biochemical communication network in body. It is focused on discovering, licensing, developing, and commercializing treatments that control endocannabinoid systems. The company pursues technologies and programs that offer proprietary approaches to cannabinoid-based therapies, also those derived from the cannabis plant and synthetic cannabinoids, as well as new chemical entities and compounds. The firm's flagship program is designed to be a patent-protected cannabinoid drug combination treatment for a rare and orphan disease.

About OCTO Eightco Holdings Inc.

Eightco Holdings Inc operates in three main businesses: Forever 8 Inventory Cash Flow Solution, Web3 Business, and Packaging Business. Forever 8 focuses on purchasing inventory for e-commerce retailers and is part of its Inventory Solution Business. Web3 Business but has no intention of continuing this business at this time. The Packaging Business manufactures and sells custom packaging for a wide variety of products and helps customers generate brand awareness and promote brand image through packaging. The Company's two reportable segments were the Inventory Management Solutions segment and the Corrugated segment. Key revenue is generated from Inventory Management Solutions segment.

Share on Social Networks: